Institution statistics

ASPER BIOTECH LTD - Estonia 

Ranking results:

Past rankings:
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:70
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 10
As coordinator: 0
As participant: 10
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 0 2.999.952 158.382 1
2012 0 6.000.000 500.000 1
2009 0 3.992.110 282.921 2
2008 0 2.971.000 742.750 1
2006 0 11.095.974 781.845 2
2005 0 573.922 81.989 1
2004 0 8.995.329 599.533 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
FONDAZIONE TELETHON2
HEINRICHHEINEUNIVERSITAET DUESSELDORF2
KAROLINSKA INSTITUTE2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
THE UNIVERSITY OF LIVERPOOL2
ACZON1
APREA AB1
AQUAMARIJN MICRO FILTRATION BV1
BEIJING UNIVERSITY OF CHINESE MEDICINE1
BIOANALYTICAL TECHNOLOGIES1
BITOP AKTIENGESELLSCHAFT FUER BIOTECHNISCHE OPTIMIERUNG1
BRUNEL UNIVERSITY1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CENTRO DE NEUROSCIENCIAS DE COIMBRA1
CHARLES UNIVERSITY PRAGUE1
CHINA CAPITAL MEDICAL UNIVERSITY1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CMC TASLY GROUP BV1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSORZIO INTERUNIVERSITARIO BIOTECNOLOGIE1
CRANFIELD UNIVERSITY1
CYCLACEL1
DANISH CANCER SOCIETY1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EMPRESA DE CONSULTORIA EM BIOTECNOLOGIA LDA1
FERMENTAS1
FONDATION ASILE DES AVEUGLES1
FORSCHUNGSVERBUND BERLIN EV1
FUNDACAO DA FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA1
FUNDACIO IMIM1
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
GANYMED PHARMACEUTICALS1
HEINRICH PETTE LNSTITUT FUER EXPERIMENTELLE VIROLOGIE UND IMMUNOLOGIE AN DER UNIVESIT T HAMBURG1
INSTITUT GUSTAVE ROUSSY1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTE OF BIOPHYSICS ACADEMY OF SCIENCES OF THE CZECH REPUBLIC1
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL1
INSTITUTE OF MEDICINAL PLANT DEVELOPMENT CHINESE ACADEMY OF MEDICAL SCIENCES1
INSTITUTO DE ENGENHARIA DE SISTEMAS E COMPUTADORES PARA OS MICROSISTEMAS E NANOTECNOLOGIAS1
INSTITUTO DE TECNOLOGIA QUIMICA E BIOLOGICA UNIVERSIDADE NOVA DE LISBOA1
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER1
ISTITUTO ONCOLOGICO VENETO1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
JOHANNES GUTENBERG UNIVERSITAET MAINZ1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAET MUENCHEN1
LEIDEN UNIVERSITY MEDICAL CENTER1
LEUKOCARE1
LI DAN JIANG1
LONDON SOUTH BANK UNIVERSITY1
MAGYAR TUDOMANYOS AKADEMIA SZEGEDIBIOLOGIAI KUTATOKOZPONT1
MEDICAL RESEARCH COUNCIL1
NATIONAL CANCER REGISTRY BOARD1
OLIGOVATION AB1
OLYMPUS LIFE SCIENCE RESEARCH EUROPA1
PHARMACOGENOMIC INNOVATIVE SOLUTIONS LIMITED1
PHILIPPS UNIVERSITAET MARBURG1
PHILIPPSUNIVERSITAET MARBURG1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
QUIATECH AB1
REGINA ELENA CANCER INSTITUTE1
RHEINISCHE FRIEDRICH WILHELMS UNIVERSITAET BONN1
ROYAL BOTANIC GARDENS KEW1
RUHR UNIVERSITAET BOCHUM1
SCHERING1
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI1
SERVICIO MADRILENO DE SALUD1
SHANGHAI INSTITUTE OF ACUPUNCTURE MOXIBUSTION AND MERIDIANS1
SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE1
SILEX MICROSYSTEMS AB1
STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA1
STICHTING KATHOLIEKE UNIVERSITEIT1
TARTU ULIKOOL1
TEPNEL LIFE SCIENCES PLC1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE NETHERLANDS CANCER INSTITUTE1
THE NORWEGIAN RADIUMHOSPITAL1
THE PROVOST FELLOWS & SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN1
THE UNIVERSITY OF HONG KONG1
THE UNIVERSITY OF MANCHESTER1
TRENZYME1
UNIVERSIDAD DE ALCALA1
UNIVERSIDADE DO MINHO1
UNIVERSITA DEGLI STUDI DI FERRARA1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITA DEGLI STUDI DI TRIESTE1
UNIVERSITAET WIEN1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITE LIBRE DE BRUXELLES1
UNIVERSITEIT LEIDEN1
UNIVERSITEIT TWENTE1
UNIVERSITEIT UTRECHT1
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY MEDICAL CENTER UTRECHT1
Constancy:

Total number of partners:115

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 115

Frequent / Rare Partner Ratio: 0

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES7
RTD HORIZONTAL TOPICS5
SOCIAL AND ECONOMIC CONCERNS2
PHYSICAL AND EXACT SCIENCES1
INDUSTRY AND TECHNOLOGY1
MEASUREMENTS AND STANDARDS1

Project overview:

Start dateProjectacronymrolefundingpartners
2013-09-01Personalisation of tREatment In Cardiovascular disease through next generation sequencing in Adverse Drug Reactions PREDICTION-ADRparticipant2.999.9526
2012-09-01Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients CTCTRAPparticipant6.000.00012
2009-05-01Good Practice in Traditional Chinese medicine research in the Post-genomic Era GP-TCMparticipant995.10030
2009-02-01High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation TECHGENEparticipant2.997.01012
2008-11-01Gene therapy for inherited severe photoreceptor diseases AAVEYEparticipant2.971.0004
2006-08-01Novel molecular diagnostic tools for the prevention and diagnosis of pancreatic cancer MOLDIAG-PACAparticipant8.434.59121
2006-02-01Development of a complete integrated SNP analysis system SNIP2CHIPparticipant2.661.3837
2005-08-30Array based sequencing-by-synthesis ARRAYSBSparticipant573.9227
2004-02-15New applications for compatible solutes from Extremophiles (HOTSOLUTES) HOTSOLUTESparticipant995.32910
2004-02-01Mutant p53 as target for improved cancer treatment MUTP53participant8.000.00016

Alias institution names:
  • ASPER BIOTECH

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum